This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Centre Hospitalier Regional Universitaire Besancon, Etablissement Francais Du Sang, National Institute of Health and Medical Research. Active years: 2020-2023.
Location History:
- Besancon, FR (2020)
- Placey, FR (2023)
Company Filing History:
2 out of 2 
2 out of 28 
2 out of 1,853 
Years Active: 2020-2023
Title: Sylvain Perruche: Innovator in Immune Response Therapies
Introduction
Sylvain Perruche is a notable inventor based in Besançon, France. He has made significant contributions to the field of immunology, particularly in the development of therapies aimed at modulating immune responses. With two patents to his name, his work focuses on innovative compositions that leverage the body's own mechanisms to address pathological conditions.
Latest Patents
Perruche's latest patents include "Cultured phagocyte supernatant compositions" and "Disease therapy using a tolerogenic pharmaceutical preparation." The first patent describes a composition that includes a supernatant obtained from the co-culture of phagocytes with apoptotic cells. This composition is created through a series of steps that involve providing phagocytes and apoptotic cells, optionally washing them, co-culturing, and then separating the supernatant. This innovative composition has potential applications in preventing or treating pathological immune responses. The second patent outlines a method for treating or preventing such responses by administering a supernatant derived from the same co-culture process.
Career Highlights
Throughout his career, Sylvain Perruche has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and the Établissement Français du Sang. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Perruche has collaborated with notable colleagues, including Philippe Saas and Francis Bonnefoy. These partnerships have enriched his research and expanded the impact of his innovations in immunology.
Conclusion
Sylvain Perruche's work exemplifies the intersection of innovation and medical science, particularly in the realm of immune response therapies. His patents reflect a commitment to advancing our understanding and treatment of immune-related conditions.